The biopharma ecosystem is devoting significant resources to develop novel cell and gene therapies to treat cancer. In this episode of "Rx for Biotech", Chris Dokomajilar discusses trends in Biotechnology investment, licensing and partnering landscape and provides an outlook on what to expect for the remainder of 2022.